Toggle navigation
Home
Search
Services
Blog
Contact
About
A Rapid Acting Lorazepam Gel for Epileptic Seizures
Nuwayser, Es S.
Biotek, Inc., Woburn, MA, United States
Search 7 grants from Es Nuwayser
Search grants from Biotek, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Genetic and Signaling Pathways in Epithelial Thyroid Cancer
Wnt/Ca2+ Function in Development and Tumor Suppression
The Compressive Tolerance of Biological Nanomachines
Lineage Determination in Muscle
Prospective Study of Diet and Cancer in Women
Recently added grants:
Novel Targets for Stroke Intervention - Gene Discovery for Modulators of Infarction
Functional Activation of Low Affinity TILs
Nuclear pore regulation of leukemia cell metabolism and survival
Parathyroid Tumor Clonal Status as a Biomarker in Primary Hyperparathyroidism
Characterization of a Novel lncRNA in Breast Cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43NS082389-001
Application #
6011548
Study Section
Project Start
1998-07-01
Project End
1999-01-29
Budget Start
1998-12-11
Budget End
1999-01-29
Support Year
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
Biotek, Inc.
Department
Type
DUNS #
City
Woburn
State
MA
Country
United States
Zip Code
01801
Related projects
NIH 1999
N43 NS
A Rapid Acting Lorazepam Gel for Epileptic Seizures
Nuwayser, Es S. / Biotek, Inc.
NIH 1998
N43 NS
A Rapid Acting Lorazepam Gel for Epileptic Seizures
Nuwayser, Es S. / Biotek, Inc.
Comments
Be the first to comment on Es Nuwayser's grant